-
Featured Authors
-
Archives
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: healthcare
BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders
The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report that show despite the overall lingering uneasiness in the economy, biotech is continuing its growth momentum. The Super Session at the 2012 BIO International Convention was moderated by members of Ernst & Young’s life sciences leadership team: Glen Giovannetti, Gautam Jaggi and Sanjeev Wadhwa; Read More >
From Bench to Bedside in a Bioeconomy
By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program when the closing panel reinforces the opening speaker. Boston University President Robert Brown kicked off the afternoon at the Translational Research Forum at the 2012 BIO International Convention by showing how the old linear model of product development crafted after World War II no longer applies. The closing industry panel aptly remarked that a struggling economy has brought the public and private Read More >
Biotech Companies are Bringing Innovation to Global Health
By Don Joseph, CEO, BIO Ventures for Global Health In March, we at BIO Ventures for Global Health (BVGH) released a report, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape, which showed that small- to medium-sized biotechnology companies are participating in a high percentage (41 percent) of projects targeting neglected diseases of the developing world. The findings of this report were surprising, given the financial risks these companies Read More >
Take the PKD Foundation Challenge
By Jill Panetta, Chief Scientific Officer, PKD Foundation Polycystic Kidney Disease (PKD) Awareness Week has been designated the week of June 18 to 24, 2012. This week allows the PKD Foundation to be able to fulfill part of its mission to people with PKD — to increase awareness of a disease which few know about and raise the understanding and the impact that PKD has on patients and their families. Autosomal dominant polycystic kidney disease Read More >
Pregnant in Heels Covers Immunizations
BIO may not be on reality TV, but one of our favorite messages- the importance of infant immunization- was discussed in a recent episode of Bravo TV’s Pregnant in Heels. Expectant mother Nia claimed that vaccinations were unnecessary and antiquated, but maternity concierge Rosie made it clear that immunizations would protect Nia’s baby from infectious disease. Check out a recap and clips from the episode on Bravo’s website to see what happened! Also check out Read More >
